Transaction overview
01Laser Photonics Corp completed a $7.9M best-efforts public offering at $0.75 per share. H.C. Wainwright & Co. acted as exclusive placement agent for the financing.
- Financing type
- Best-Efforts Public Offering
- Announcement date
- —
- SEC disclosure date
- Sep 14, 2026
- Pricing date
- Sep 10, 2026
- Closing date
- Sep 14, 2026
- Filing date
- Sep 15, 2026
- Status
- Closed
- Market cap before SEC disclosure
- $27.3M
- Prior closing price
- $0.695
- Raise as % of market cap
- 28.8%
Market data · FMP
- Historical market cap
- $27,342,447
- Market date
- Sep 11, 2026
- Closing price
- $0.695
- Latest reported shares outstanding
- 47,584,490
- Latest reported float shares
- 32,454,382
- Share-data date
- Sep 29, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.
Financial Modeling Prep ↗Financing terms
02Equity
- Common shares issued
- 10,500,000
- Price per share
- $0.75
- Pre-funded warrants
- —
- Pre-financing shares disclosed in filing
- —
- Shares outstanding after financing
- —
Series B-1 investor warrants
- Warrant shares
- 10,500,000
- Cash exercise price
- $0.75
- Term
- Five years from Initial Exercise Date (issuance).
- Initial exercisability
- —
- Beneficial ownership limits
- —
View disclosed legal provisions
Cashless exercise: Available when an effective registration statement or prospectus for issuance/resale is unavailable, under the warrant formula.
Anti-dilution: —
Series B-2 investor warrants
- Warrant shares
- 10,500,000
- Cash exercise price
- $0.75
- Term
- Twenty-four months from Initial Exercise Date (issuance).
- Initial exercisability
- —
- Beneficial ownership limits
- —
View disclosed legal provisions
Cashless exercise: Available when an effective registration statement or prospectus for issuance/resale is unavailable, under the warrant formula.
Anti-dilution: —
Placement agent warrants
- Warrant shares
- 735,000
- Cash exercise price
- $0.9375
- Term
- Five years from commencement of sales in this offering; commencement date unconfirmed.
- Initial exercisability
- —
- Beneficial ownership limits
- —
Compensation warrants are excluded from investor warrant coverage.
View disclosed legal provisions
Cashless exercise: —
Anti-dilution: —
Fees & transaction economics
03- Placement agent / underwriting fee
- 7%
- Agent fee amount
- $551,250
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
7% cash placement fee ($551,250) plus 735,000 agent warrants; agent legal expense reimbursement capped at $50,000, not recorded as actual expense. Proceeds before other expenses are $7,323,750, not final net proceeds.
Transaction participants
04Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
Filing evidence & original calculations
0.75
The public offering price for each Share and accompanying Common Warrants is $0.75.Original source ↗
7
cash fee equal to seven percent (7.0%) of the aggregate gross proceedsOriginal source ↗
2026-09-14
closed its previously announced public offering on September 14, 2026Original source ↗
7% cash placement fee ($551,250) plus 735,000 agent warrants; agent legal expense reimbursement capped at $50,000, not recorded as actual expense. Proceeds before other expenses are $7,323,750, not final net proceeds.
In addition, we have agreed to reimburse the Placement Agent at closing for legal expenses incurred by the Placement Agent in connection with this offering in an aggregate amount of up to $50,000.Original source ↗
FMP reported market cap; as of 2026-09-11.
{"provider": "FMP", "symbol": "LASE", "date": "2026-09-11", "marketCap": 27342447}Original source ↗
0.75
The Common Warrants offered hereby will have an exercise price of $0.75 per share and will be exercisable upon issuance (the “Initial Exercise Date”).Original source ↗
5
The series B-1 warrants will expire five (5) years from the Initial Exercise Date and the series B-2 warrants will expire twenty-four (24) months from the Initial Exercise Date.Original source ↗
Five years from Initial Exercise Date (issuance).
The Common Warrants offered hereby will have an exercise price of $0.75 per share and will be exercisable upon issuance (the “Initial Exercise Date”). The series B-1 warrants will expire five (5) years from the Initial Exercise Date and the series B-2 warrants will expire twenty-four (24) months from the Initial Exercise Date.Original source ↗
Available when an effective registration statement or prospectus for issuance/resale is unavailable, under the warrant formula.
If at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance or resale of the Shares of Common Stock to be issued upon exercise of the Common Warrants, then as an alternative to payment of the exercise price in immediately available funds, the holder may elect to exercise the Common Warrant through a cashless exerciseOriginal source ↗
0.75
The Common Warrants offered hereby will have an exercise price of $0.75 per share and will be exercisable upon issuance (the “Initial Exercise Date”).Original source ↗
2
The series B-1 warrants will expire five (5) years from the Initial Exercise Date and the series B-2 warrants will expire twenty-four (24) months from the Initial Exercise Date.Original source ↗
Twenty-four months from Initial Exercise Date (issuance).
The Common Warrants offered hereby will have an exercise price of $0.75 per share and will be exercisable upon issuance (the “Initial Exercise Date”). The series B-1 warrants will expire five (5) years from the Initial Exercise Date and the series B-2 warrants will expire twenty-four (24) months from the Initial Exercise Date.Original source ↗
Available when an effective registration statement or prospectus for issuance/resale is unavailable, under the warrant formula.
If at the time of exercise there is no effective registration statement registering, or the prospectus contained therein is not available for, the issuance or resale of the Shares of Common Stock to be issued upon exercise of the Common Warrants, then as an alternative to payment of the exercise price in immediately available funds, the holder may elect to exercise the Common Warrant through a cashless exerciseOriginal source ↗
735000
Placement Agent Warrants to Purchase Up to 735,000 Shares of Common StockOriginal source ↗
0.9375
which Placement Agent Warrants are exercisable at an exercise price equal to 125% of the public offering price and will terminate five (5) years from the date of the commencement of sales in this offering.Original source ↗
5
which Placement Agent Warrants are exercisable at an exercise price equal to 125% of the public offering price and will terminate five (5) years from the date of the commencement of sales in this offering.Original source ↗
Five years from commencement of sales in this offering; commencement date unconfirmed.
which Placement Agent Warrants are exercisable at an exercise price equal to 125% of the public offering price and will terminate five (5) years from the date of the commencement of sales in this offering.Original source ↗